Kidswell Bio Corporation
Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.
4584 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区新川一丁目２番１２号
- Website:
- https://www.kidswellbio.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kidswell Bio Corporation is a biopharmaceutical company focused on the research and development of innovative pharmaceuticals and therapeutics, with a particular emphasis on pediatric diseases. Formerly known as Gene Techno Science and founded in 2001, the company's operations are centered around three core business segments: Biosimilars, leveraging its expertise in cell line development and CMC; New Biologics, which includes the development of novel antibodies for cancer and eye diseases; and Cell Therapy, which pioneers next-generation cellular medicines based on SHED (Stem cells from Human Exfoliated Deciduous teeth) to address unmet medical needs.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Kidswell Bio Corporation and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-30 08:33 |
Regulatory News Service
臨時報告書
|
Japanese | 24.0 KB | |
| 2025-06-27 08:36 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2025-06-27 08:35 |
Regulatory News Service
内部統制報告書－第25期(2024/04/01－2025/03/31)
|
Japanese | 22.2 KB | |
| 2025-06-27 08:33 |
Annual Report
有価証券報告書－第25期(2024/04/01－2025/03/31)
|
Japanese | 1.2 MB | |
| 2025-03-31 09:16 |
Regulatory News Service
臨時報告書
|
Japanese | 18.2 KB | |
| 2024-12-26 07:56 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 543.7 KB | |
| 2024-11-14 07:50 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-11-14 07:47 |
Interim Report
半期報告書－第25期(2024/04/01－2025/03/31)
|
Japanese | 185.0 KB | |
| 2024-06-27 09:12 |
Regulatory News Service
臨時報告書
|
Japanese | 22.5 KB | |
| 2024-06-27 09:11 |
Regulatory News Service
内部統制報告書－第24期(2023/04/01－2024/03/31)
|
Japanese | 21.2 KB | |
| 2024-06-27 09:11 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-06-27 09:10 |
Annual Report
有価証券報告書－第24期(2023/04/01－2024/03/31)
|
Japanese | 1.1 MB | |
| 2024-06-07 08:39 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-06-07 08:36 |
Regulatory News Service
訂正有価証券報告書－第23期(2022/04/01－2023/03/31)
|
Japanese | 692.5 KB | |
| 2024-02-14 07:35 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB |
Automate Your Workflow. Get a real-time feed of all Kidswell Bio Corporation filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Kidswell Bio Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
